drugset / Trial / NCT01033526

Symptomatic Treatment of Common Cold Symptoms

NCT01033526

Phase 4 Completed 388 enrolled Bayer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A two-arm, multicenter, randomized, double-blind, single dose placebo-controlled parallel groups study evaluating efficacy and tolerability of 800 mg Acetylsalicylic Acid (Aspirina C) in adult patients with a common cold during a two hour in patient phase; and a follow-up period of five days of home treatment as required.

Timeline

Start
2005-10
Primary completion
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 400 mg
Background Vitamin C Other / unclassified 240 mg

Indications